Amedeo Smart

Free Medical Literature Service


 

Amedeo

Multiple Sclerosis

  Free Subscription

11.05.2025

1 Brain
1 J Neuroimmunol
3 J Neurol
2 Mayo Clin Proc
2 Mult Scler
1 PLoS Biol



    Brain

  1. GIOVANNONI G, James L, Adeniran AA, Gold J, et al
    The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.
    Brain. 2025 May 6:awaf170. doi: 10.1093.
    >> Share


    J Neuroimmunol

  2. PETROU P, Kassis I, Levi Y, Yaghmour N, et al
    Kinetics of serum NFL and GFAP and changes in cognitive functions, in MS patients treated with repeated administrations of autologous mesenchymal stem cells (MSC-NG01).
    J Neuroimmunol. 2025;403:578613.
    >> Share


    J Neurol

  3. FREEDMAN DE, Oh J, Einstein G, Feinstein A, et al
    Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study.
    J Neurol. 2025;272:375.
    >> Share

  4. KOLB H, Shachaf Y, Fainberg K, Golan M, et al
    Intrathecal methotrexate in progressive multiple sclerosis: a phase 1 open-label study with long-term follow-up.
    J Neurol. 2025;272:374.
    >> Share

  5. HERMAN D, Tanniou J, Leray E, Pierret C, et al
    Analyzing recurrent events in multiple sclerosis: a review of statistical models with application to the MSOAC database.
    J Neurol. 2025;272:371.
    >> Share


    Mayo Clin Proc

  6. KWON S, Han KD, Jung JH, Cho EB, et al
    Risk of Autoimmune Rheumatic Diseases in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Nationwide Cohort Study in South Korea.
    Mayo Clin Proc. 2025;100:801-813.
    >> Share

  7. TORKILDSEN O
    Multiple Sclerosis, NMOSD, and the Risk of Autoimmune Diseases.
    Mayo Clin Proc. 2025;100:773-775.
    >> Share


    Mult Scler

  8. MACCARRONE D, Prados F, Ciccarelli O
    The relationship between cladribine and reduced regional grey matter volume loss in people with relapsing-remitting multiple sclerosis.
    Mult Scler. 2025 May 3:13524585251338772. doi: 10.1177/13524585251338772.
    >> Share

  9. LOREFICE L, Zivadinov R
    Treating comorbidities in multiple sclerosis is disease-modifying: Yes.
    Mult Scler. 2025 May 3:13524585251338750. doi: 10.1177/13524585251338750.
    >> Share


    PLoS Biol

  10. HILL BM, Holloway RK, Forbes LH, Davies CL, et al
    Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelination.
    PLoS Biol. 2025;23:e3003073.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016